Laks, T., Keba, E., Leiner, M., Merilind, E., Petersen, M., Reinmets, S., Väli, S., Sööt, T., Otter, K.

full record print

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice : a randomized, open-label, parallel-group, multi-center study : the DISCOVERY-beta study

author

Laks, Toivo

Keba, Ester

Leiner, Mariann

Merilind, Eero

Petersen, Mall

Reinmets, Sirje

Väli, Sille

Sööt, Terje

Otter, Karin

statement of authorship

Toivo Laks, Ester Keba, Mariann Leiner, Eero Merilind, Mall Petersen, Sirje Reinmets, Sille Väli, Terje Sööt, Karin Otter

source

Vascular health and risk management

journal volume number month

year of publication

2008

pages

6, p. 1147-1156

url

https://pubmed.ncbi.nlm.nih.gov/19337553/

ISSN

1176-6344

language

inglise

Märksõnad ja võtmesõnad

subject term

simvastatiin

kolesteroolisisaldust vähendavad ained

tolerantsus (bioloogia)

võrdlevuuringud

efektiivsus

hüperkolesteroleemia

Laks, T., Keba, E., Leiner, M., Merilind, E., Petersen, M., Reinmets, S., Väli, S., Sööt, T., Otter, K. Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice : a randomized, open-label, parallel-group, multi-center study : the DISCOVERY-beta study // Vascular health and risk management (2008) 4, 6, p. 1147-1156. https://pubmed.ncbi.nlm.nih.gov/19337553/